VALBIOTIS (EPA:ALVAL) | WebDisclosure

Basculer en Français

10411	Companies
217812	Keywords
147362	Articles
115250	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 06/20/2024 at 08:50, 1 year 10 months ago

Valbiotis : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Mai 2024
Valbiotis communique les informations mensuelles sur le nombre de droits de vote et d'actions en mai 2024. L'entreprise est spécialisée dans les compléments alimentaires pour la santé cardiovasculaire

Droits De Vote Capital Social Valbiotis Compléments Alimentaires Troubles Métaboliques
BRIEF

published on 06/17/2024 at 17:45, 1 year 10 months ago

Valbiotis présentera aux sessions de l’American Diabetes Association

Valbiotis Compléments Alimentaires American Diabetes Association TOTUM•63 Diabète
BRIEF

published on 06/17/2024 at 17:45, 1 year 10 months ago

Valbiotis to present at American Diabetes Association sessions

Diabetes Valbiotis American Diabetes Association TOTUM•63 Food Supplements
PRESS RELEASE

published on 06/17/2024 at 17:40, 1 year 10 months ago

Valbiotis sélectionnée aux 84èmes sessions scientifiques de l’American Diabetes Association
Valbiotis sélectionnée pour présenter les résultats cliniques de la Phase II/III REVERSE-IT de TOTUM•63 lors des 84èmes sessions scientifiques de l’American Diabetes Association

Valbiotis Prevention American Diabetes Association TOTUM•63 Diabète De Type 2
PRESS RELEASE

published on 06/17/2024 at 17:40, 1 year 10 months ago

Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results from TOTUM•63 Phase II/III REVERSE-IT study in prediabetes and type 2 diabetes at the American Diabetes Association’s 84th Scientific Sessions

Valbiotis American Diabetes Association TOTUM•63 Clinical Results Scientific Sessions
BRIEF

published on 06/06/2024 at 10:58, 1 year 11 months ago

Valbiotis Terminate Licensing Agreement with Nestlé Health Science

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
BRIEF

published on 06/06/2024 at 10:58, 1 year 11 months ago

Valbiotis met fin à son accord de licence avec Nestlé Health Science

Valbiotis TOTUM•63 Traitement Du Diabète Contrat De Licence Nestlé Sciences De La Santé
PRESS RELEASE

published on 06/06/2024 at 10:53, 1 year 11 months ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis regains full ownership of TOTUM•63, a plant-based dietary supplement for prediabetes and early type 2 diabetes, after terminating agreement with Nestlé Health Science

Valbiotis Dietary Supplement TOTUM•63 Nestlé Health Science Prediabetes
BRIEF

published on 06/06/2024 at 10:49, 1 year 11 months ago

Valbiotis et Nestlé Health Science mettent fin à leur contrat de licence et d’approvisionnement

Valbiotis Compléments Alimentaires Propriété Intellectuelle TOTUM•63 Nestlé
BRIEF

published on 06/06/2024 at 10:49, 1 year 11 months ago

Valbiotis and Nestlé Health Science terminate their licensing and supply agreement

Valbiotis Intellectual Property TOTUM•63 Food Supplements Nestlé

Accesswire

Published on 05/16/2026 at 01:15, 16 hours 53 minutes ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 17 hours 8 minutes ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 18 hours 8 minutes ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 18 hours 58 minutes ago

Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 19 hours 8 minutes ago

Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency

View all ACCESSWIRE

EQS Group

Published on 05/16/2026 at 16:08, 2 hours ago

The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 21 hours 58 minutes ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 23 hours 38 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:30, 23 hours 38 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 23 hours 58 minutes ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

Les Echos

Published on 05/15/2026 at 15:08, 1 day 3 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 3 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 7 hours ago

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 9 hours ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

View all LES ECHOS COMFI WIRE